These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

352 related articles for article (PubMed ID: 28070056)

  • 1. A case of idiopathic type 1 diabetes with subsequent recovery of endogenous insulin secretion despite initial diagnosis of fulminant type 1 diabetes.
    Kaneko K; Satake C; Yamamoto J; Takahashi H; Sawada S; Imai J; Yamada T; Katagiri H
    Endocr J; 2017 Mar; 64(3):369-374. PubMed ID: 28070056
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical outcomes in youth beyond the first year of type 1 diabetes: Results of the Pediatric Diabetes Consortium (PDC) type 1 diabetes new onset (NeOn) study.
    Cengiz E; Cheng P; Ruedy KJ; Kollman C; Tamborlane WV; Klingensmith GJ; Gal RL; Silverstein J; Lee J; Redondo MJ; Beck RW;
    Pediatr Diabetes; 2017 Nov; 18(7):566-573. PubMed ID: 27758023
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ketosis onset type 2 diabetes had better islet β-cell function and more serious insulin resistance.
    Lu H; Hu F; Zeng Y; Zou L; Luo S; Sun Y; Liu H; Sun L
    J Diabetes Res; 2014; 2014():510643. PubMed ID: 24829925
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diabetic ketoacidosis at the onset of type 1 diabetes is associated with future HbA1c levels.
    Fredheim S; Johannesen J; Johansen A; Lyngsøe L; Rida H; Andersen ML; Lauridsen MH; Hertz B; Birkebæk NH; Olsen B; Mortensen HB; Svensson J;
    Diabetologia; 2013 May; 56(5):995-1003. PubMed ID: 23389397
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ketosis prone diabetes presenting as fulminant type 1 diabetes.
    Krompa K; Barka I; Malard S; Tatulashvili S; Baudry C; Bihan H; Fysekidis M
    Pan Afr Med J; 2018; 31():38. PubMed ID: 30918564
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ketosis-prone atypical diabetes in Cameroonian people with hyperglycaemic crisis: frequency, clinical and metabolic phenotypes.
    Lontchi-Yimagou E; Nguewa JL; Assah F; Noubiap JJ; Boudou P; Djahmeni E; Balti EV; Atogho-Tiedeu B; Gautier JF; Mbanya JC; Sobngwi E
    Diabet Med; 2017 Mar; 34(3):426-431. PubMed ID: 27657549
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low hemoglobin A1c levels in a patient with diabetic ketoacidosis: Fulminant type 1 diabetes mellitus.
    Keskin M; Savaş-Erdeve Ş; Çetinkaya S; Aycan Z
    Turk J Pediatr; 2018; 60(2):201-205. PubMed ID: 30325130
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A case of type 2 diabetes mellitus in an elderly patient with rapid attenuation of insulin secretion that resembled fulminant type 1 DM but with incomplete beta cell damage.
    Tamura Y; Araki A; Chiba Y; Ishimaru Y; Ishimaru Y; Horiuchi T; Mori S; Hosoi T
    Endocr J; 2006 Oct; 53(5):633-7. PubMed ID: 16896262
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multinational study in children and adolescents with newly diagnosed type 1 diabetes: association of age, ketoacidosis, HLA status, and autoantibodies on residual beta-cell function and glycemic control 12 months after diagnosis.
    Mortensen HB; Swift PG; Holl RW; Hougaard P; Hansen L; Bjoerndalen H; de Beaufort CE; Knip M;
    Pediatr Diabetes; 2010 Jun; 11(4):218-26. PubMed ID: 19708904
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transition of blood glucose level in a patient with pregnancy-associated fulminant type 1 diabetes mellitus.
    Ichikawa T; Kitae A; Takeda S; Sueyoshi A; Hamaguchi M; Fukui M
    J Diabetes Investig; 2021 May; 12(5):894-896. PubMed ID: 33000569
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Changes in circulating adiponectin, leptin, glucose and C-peptide in patients with ketosis-prone diabetes.
    Gupta P; Liu Y; Lapointe M; Yotsapon T; Sarat S; Cianflone K
    Diabet Med; 2015 May; 32(5):692-700. PubMed ID: 25407468
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical features of a young Japanese woman having marked obesity and abrupt onset of diabetes mellitus with ketoacidosis.
    Kobayashi J; Sasaki T; Ishiba Y; Watanabe M
    Diabetes Res Clin Pract; 2002 Dec; 58(3):167-72. PubMed ID: 12413775
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of insulin glargine on endogenous insulin secretion and beta-cell function in Japanese type 2 diabetic patients using oral antidiabetic drugs.
    Ohta A; Kato H; Murayama K; Hashimoto E; Murakami M; Nishine A; Ohshige T; Sada Y; Asai S; Kawata T; Nagai Y; Katabami T; Tanaka Y
    Endocr J; 2014; 61(1):13-8. PubMed ID: 24064478
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of initial insulin dosage on blood glucose dynamics of children and adolescents with newly diagnosed type 1 diabetes mellitus.
    Wang Y; Gong C; Cao B; Meng X; Wei L; Wu D; Liang X; Li W; Liu M; Gu Y; Su C
    Pediatr Diabetes; 2017 May; 18(3):196-203. PubMed ID: 26947770
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ketoacidosis at onset of type 1 diabetes is a predictor of long-term glycemic control.
    Shalitin S; Fisher S; Yackbovitch-Gavan M; de Vries L; Lazar L; Lebenthal Y; Phillip M
    Pediatr Diabetes; 2018 Mar; 19(2):320-328. PubMed ID: 28568379
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Insulin secretion measured by stimulated C-peptide in long-established Type 1 diabetes in the Diabetes Control and Complications Trial (DCCT)/ Epidemiology of Diabetes Interventions and Complications (EDIC) cohort: a pilot study.
    McGee P; Steffes M; Nowicki M; Bayless M; Gubitosi-Klug R; Cleary P; Lachin J; Palmer J;
    Diabet Med; 2014 Oct; 31(10):1264-8. PubMed ID: 24836354
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fulminant Type 1 Diabetes Mellitus Complicated with a Life-threatening Electrolyte Abnormality and Abnormal Electrocardiogram Findings.
    Kinoshita T; Kaneto H; Kawasaki F; Anno T; Kurihara T; Yamada H; Oshiro Y; Miyashita N; Okimoto N; Kaku K
    Intern Med; 2018 Sep; 57(18):2685-2688. PubMed ID: 29709945
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of new-onset type 1 diabetes with peptide DiaPep277 is safe and associated with preserved beta-cell function: extension of a randomized, double-blind, phase II trial.
    Raz I; Avron A; Tamir M; Metzger M; Symer L; Eldor R; Cohen IR; Elias D
    Diabetes Metab Res Rev; 2007 May; 23(4):292-8. PubMed ID: 17124720
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Startling hyperglycaemia with transient beta cell stunning in a patient with type 2 diabetes.
    Sato Y; Kakizawa M; Aso SI; Takayama M; Yamashita K; Miyamoto T; Aizawa T
    Endocr J; 2020 Jan; 67(1):95-98. PubMed ID: 31597815
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fulminant Type 1 diabetes in a pregnant woman as an initial manifestation of the insulin autoimmune syndrome.
    Kim HS; Lee TY; Kim EY; Choi JH; Kim SY; Hwang YC; Kang JH; Ahn KJ; Chung HY; Jeong IK
    Diabet Med; 2012 Oct; 29(10):1335-8. PubMed ID: 22356444
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.